Neogenomics
NEO on Nasdaq. NeoGenomics sells cancer testing and laboratory results to doctors and hospitals. Market value $2.5bn.
Price checks use the past 12 months to June 2026. Quality checks use five annual reports, the latest for the year to December 2025.
Should I look at this?
Not a fit for our list right now
Why it could be worth it
See Industrials stocks that passed both tests
This is not advice. Check the numbers below.
For every $100 of what the whole company costs, it produced $-0.35 of spare cash in the past 12 months. A savings account pays about $4.
The filings do not give us enough to work this out.
Each dollar kept in the business earns -7 cents a year. Above 10 is good.
Quality score: 40 of 100. Price score: 0 of 100. Our list needs 70 on quality and 60 on price.
$16.51 a share, 134% above its 1-year low
Over the past year the price has ranged from $7.07 to $20.15.
Pays no dividend
Prices from Tuesday’s close (6 October).
Five years of cash, in billions
Spare cash swings from quarter to quarter here: a shortfall of $7 million in the past 12 months, a shortfall of $22 million in the year to December 2025.
| Revenue | |||||
| Revenue | $484m | $510m | $592m | $661m | $727m |
| Operating margin | |||||
| Operating margin | -24.5% | -30.9% | -18.2% | -13.9% | -15.9% |
| Debt to equity | |||||
| Debt to equity | 0.48 | 0.54 | 0.57 | 0.60 | 0.41 |
| Shares outstanding | |||||
| Shares outstanding | 0.13bn | 0.13bn | 0.13bn | 0.13bn | 0.13bn |
Health checks
- Free cash flow positive0 of 5 years
- Accounting looks honest (Beneish)Nothing unusual
- Financial strength (Piotroski)6 of 9
- Profit backed by cash (accruals)Yes
- Debt0.41× equity
- Revenue growth, five yearsStrong, 10.4% a year
- Buying back its own sharesRoughly flat
The quarter to June 2026
How the business did, compared with the same quarter a year earlier.
- Sales: $202 million last quarter, up 11% on a year ago.
- Profit: $2 million, after a loss of $45 million a year ago.
- It loses 9 cents on each $1 of sales, compared with 17 cents a year earlier.
- Over the past 12 months it spent $7 million more cash than it brought in, compared with $19 million a year earlier.
- 2% more shares than a year ago. Each share owns a bit less of the company.
- Sales grew on a year ago in each of the last 4 quarters.
| Quarter to | Amount |
|---|---|
| September 2024 | $168m |
| December 2024 | $172m |
| March 2025 | $168m |
| June 2025 | $181m |
| September 2025 | $188m |
| December 2025 | $190m |
| March 2026 | $187m |
| June 2026 | $202m |
| Quarter to | Amount |
|---|---|
| September 2024 | -$18m |
| December 2024 | -$15m |
| March 2025 | -$26m |
| June 2025 | -$45m |
| September 2025 | -$27m |
| December 2025 | -$10m |
| March 2026 | -$17m |
| June 2026 | $2m |
From the company's quarterly reports to the SEC.
Dates
- Next results (estimated)
- n/a
- Last annual report (10-K)
- 17 February 2026
- Next quarterly (estimated, 10-Q)
- 27 October 2026
Who owns it
2 long-term investors we follow own it, unchanged from 2 last quarter. 266 funds in all.
- GAMCO InvestorsMario Gabelli
- Value
- $1m
- Share of fund
- <0.1%
- Beutel GoodmanBeutel Goodman team
- Value
- $0
- Share of fund
- 0.0%
| Fund | Value | Share of that fund | Change |
|---|---|---|---|
| GAMCO InvestorsMario Gabelli | $1m | <0.1% | |
| Beutel GoodmanBeutel Goodman team | $0 | 0.0% |
Largest holders overall
- BlackRock$304mAdded
- First Light Asset Management$179mAdded
- First Trust Advisors LP$148mAdded
- Greenhouse Funds LLLP$125mCut
- Vanguard Portfolio Management$118mAdded
- Vanguard Capital Management$84m
- State Street$78mAdded
- Nomura Asset Management International$74mAdded
- Braidwell LP$72mCut
- Schroder Investment Management Group$62mAdded
From 13F filings for the quarter ended 30 June 2026.
Big holders and activists
8 investors own more than 5%.
- BlackRock, Inc.Passive investor15.6%+1.0 ptsSince 30 June 2026
- Mathew P. ArensPassive investorat least 8.4%−2.5 pts(filed with 1 related holder)Since 30 June 2026
- First Trust Portfolios L.P.Passive investorat least 7.8%(filed with 2 related holders)Since 30 June 2026
- Greenhouse Funds LLLPPassive investorat least 7.1%+1.3 pts(filed with 2 related holders)Since 31 March 2026
- Vanguard Portfolio ManagementPassive investor5.9%Since 31 March 2026
- Vanguard Capital ManagementPassive investor5.1%Since 31 March 2026
- Millennium Management LLCPassive investorat least 2.8%−2.6 pts(filed with 1 related holder)Since 30 June 2025
- Millennium Management LLCPassive investorat least 1.7%−3.3 pts(filed with 2 related holders)Since 31 March 2026
- JANUS HENDERSON GROUP PLCPassive investorSold down below 5%Since 31 December 2024
- T. Rowe Price Investment Management, Inc.Passive investorSold down below 5%Since 31 March 2025
- The Vanguard GroupPassive investorSold down below 5%Since 13 March 2026
| Holder | Stake | Since | |
|---|---|---|---|
BlackRock, Inc. Passive investor | 15.6%+1.0 pts | 30 June 2026 | |
Mathew P. Arens Passive investor | at least 8.4%−2.5 pts (filed with 1 related holder) | 30 June 2026 | |
First Trust Portfolios L.P. Passive investor | at least 7.8% (filed with 2 related holders) | 30 June 2026 | |
Greenhouse Funds LLLP Passive investor | at least 7.1%+1.3 pts (filed with 2 related holders) | 31 March 2026 | |
Vanguard Portfolio Management Passive investor | 5.9% | 31 March 2026 | |
Vanguard Capital Management Passive investor | 5.1% | 31 March 2026 | |
Millennium Management LLC Passive investor | at least 2.8%−2.6 pts (filed with 1 related holder) | 30 June 2025 | |
Millennium Management LLC Passive investor | at least 1.7%−3.3 pts (filed with 2 related holders) | 31 March 2026 | |
JANUS HENDERSON GROUP PLC Passive investor | Sold down below 5% | 31 December 2024 | |
T. Rowe Price Investment Management, Inc. Passive investor | Sold down below 5% | 31 March 2025 | |
The Vanguard Group Passive investor | Sold down below 5% | 13 March 2026 |
From Schedule 13D and 13G filings: anyone owning more than 5% must file one.
What insiders did
No insider bought shares on the open market in the last 12 months. 4 sold $1m, $695,596 of it under preset trading plans.
- Aunan Greg DChief Accounting OfficerSold
- Date
- 4 August 2026
- Shares
- 20,000
- Price
- $16.07
- Value
- $321,400
- TETRAULT LYNN A.DirectorSoldunder a preset trading plan
- Date
- 15 June 2026
- Shares
- 5,307
- Price
- $11.10
- Value
- $58,908
- TETRAULT LYNN A.DirectorSoldunder a preset trading plan
- Date
- 9 June 2026
- Shares
- 5,307
- Price
- $11.29
- Value
- $59,916
- Stone WarrenPres & Chief Operating OfficerSoldunder a preset trading plan
- Date
- 20 January 2026
- Shares
- 22,128
- Price
- $12.50
- Value
- $276,600
- Olivo Alicia CEVP, GC & Business DevelopmentSoldunder a preset trading plan
- Date
- 25 November 2025
- Shares
- 20,916
- Price
- $12.00
- Value
- $250,992
- Olivo Alicia CEVP, GC & Business DevelopmentSoldunder a preset trading plan
- Date
- 16 October 2025
- Shares
- 4,918
- Price
- $10.00
- Value
- $49,180
| Date | Who | Did | Shares | Price | Value |
|---|---|---|---|---|---|
| 4 August 2026 | Aunan Greg D Chief Accounting Officer | Sold | 20,000 | $16.07 | $321,400 |
| 15 June 2026 | TETRAULT LYNN A. Director | Sold under a preset trading plan | 5,307 | $11.10 | $58,908 |
| 9 June 2026 | TETRAULT LYNN A. Director | Sold under a preset trading plan | 5,307 | $11.29 | $59,916 |
| 20 January 2026 | Stone Warren Pres & Chief Operating Officer | Sold under a preset trading plan | 22,128 | $12.50 | $276,600 |
| 25 November 2025 | Olivo Alicia C EVP, GC & Business Development | Sold under a preset trading plan | 20,916 | $12.00 | $250,992 |
| 16 October 2025 | Olivo Alicia C EVP, GC & Business Development | Sold under a preset trading plan | 4,918 | $10.00 | $49,180 |
From Form 4 filings: insiders must report trades in their own company's shares within two days.
Warning signs in its filings
Problems the company itself reported to the SEC, in its own words.
None of the warning signs we check for were found.
We look for five warning signs: doubt it can keep going, weak checks on its own accounts, a notice that its past accounts can't be relied on, a change of auditor, and one customer bringing in a big share of sales. We don't check lawsuits, investigations or debt yet.
We checked the auditor's report, internal controls, restatement notices, auditor changes and big customers in the 10-K filed 17 Feb 2026, plus the 10-Q filed 28 Jul 2026 and 9 later 8-Ks.
A 10-K is the yearly report every US company files with the SEC. An 8-K is a short notice of a big event.
What could go wrong
Cheap for a reason is the question the numbers cannot answer.
Whether the price already reflects the risks is what the deep dive is for.
The deep dive
Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.
- What the business is worth, as a range, and the margin of safety at today’s price
- Prices to start buying, buy, and buy hard
- The three things that would make this a mistake
- Every number footnoted to the filing it came from
Your first deep dive is free.
Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.